The Personal Toll of Failing to Act

It’s day three of ‘Weed Week’ here at Money Morning. And hopefully so far you’ve started to appreciate there’s more to this opportunity than meets the eye.

It’s really nothing to do with ‘getting high’. And it’s more than naïve jokes about Nimbin and hippies.

There’s a personal toll that people pay day in day out that legal cannabis might be able to alleviate.

It’s all well and good to read about the plight of people. It’s another thing to see it firsthand. Sadly in our case, this very much applies.

The following is an extract from a stock recommendation we recently published. We can’t tell you what the stock was…that’d be giving too much away. To tell you wouldn’t be fair to our paying subscribers — but keep one eye on your inbox tomorrow to find out more.

This extract we’re republishing because it’s a story that we’ve seen firsthand. It’s something we see most weeks when we see this person. When you see and experience —firsthand — the pain and suffering some people go through, it gives you a different perspective on things.

And when you see the benefit certain therapies can have, well that changes things again entirely.



Aaron suffers in silence

Aaron (name changed for privacy) is in his mid-20s. On the face of it, he’s a perfectly normal, happy, outgoing person.

If you looked at him you wouldn’t think otherwise.

But just by looking at someone, you never really understand what’s really going on inside. On the face of it, you might think that because he seems fine, everything is fine.

But what if it’s not.

What if the reality is far, far from the appearance?

What if deep down, he’s in pain? What if it’s chronic, often debilitating pain stemming from a number of illnesses and physical problems?

You only ever see him at his ‘best’. But at home — when you’re not around — he’s often in the foetal position in the bathroom, barely able to sit let alone stand. Sleepless nights, insufferable days.

And on the odd occasion, when things are manageable (the pain never really subsides), you’ll see him out at a social event. But you don’t see him all the time.

In fact, you realise that he often misses events. Of course, if Aaron’s a friend of yours you’ll know the real reason. You’ll know that day-to-day living is in fact a massive battle. That his chronic illness makes everything a struggle.

He misses out on social events. He can’t work a normal job. He can manage a relationship, but only because his partner is one of the most caring people on the face of the earth. Part-time partner, part-time carer.

Aaron is someone I know. One of the nicest people I’ve ever met. But he suffers from chronic pain. I, like others, wish we could help and make his pain just disappear, but we can’t.

And truth be told, we’ll never really understand what it’s like to suffer from debilitating chronic pain. No one really understands unless you suffer from it yourself.

And you’ll know that just because someone doesn’t display symptoms, doesn’t mean they’re not in pain. Sadly, the instance of chronic pain globally isn’t small, isolated cases.

While Aaron’s one of the more extreme examples of chronic pain sufferers, there are billions more in the same boat.

Estimates are that more than 1.5 billion people worldwide suffer from chronic pain. In the US, chronic pain is the number one reason for long-term disability.

This chronic pain then leads to other issues with as many as 77% of sufferers leading to states of depression. And to make matters worse the, US National Institutes of Health (NIH) says, ‘pain affects more Americans than diabetes, heart disease and cancer combined.’

The traditional medical approach for many decades has been to prescribe opioids to manage pain. The problem is that many opioids are highly addictive and can lead to death.

28,000 people died in the US from opioid overdoses in 2014. And in 2016, more than 63,000 lives were lost to opioids.

In the US, that means opioids kill more people than breast cancer every year.

Therefore it should come as no great surprise that many chronic pain sufferers are now turning to medical marijuana to help with their pain and illness.


A possible win-win-win situation

Our friend, Aaron, continues to this day trying to find easy access to cannabis therapies. He has used it before to manage his pain. He will do what he can to get ongoing access to it.

In the UK his actions are technically criminal. And to be fair in Australia it’s likely they would be too. Even with the current medicinal marijuana approvals.

It’s because bureaucracy is standing in the way. For forty years the world has demonised cannabis and marijuana.

But it has real positive effects on people’s lives when applied in a medical sense. It has the potential to change lives. It maybe even has the potential to save lives.

It’s not an exact science for now. We know (as we wrote yesterday) that R&D (research and development) spending in this field is coming. We know that with looser laws countries are opening up to the opportunity.

We know that if cannabis works as medical therapy it has tangible GDP impact. It can cut healthcare costs. It can help those who might otherwise not get better…get better.

If we can shake off the stigma, if we can see this medical application of cannabis — we all stand to benefit. Those who use it for therapy benefit. Government and economies benefit. Investors in the best of the best in legal cannabis benefit.

There aren’t too many win-win-win situations in global industry. But the cannabis opportunity is what I think is as close as it gets.



Sam Volkering, Editor, Secret Crypto Network

Sam Volkering is an Editor for Money Morning and is small-cap, cryptocurrency and technology expert.

He’s not interested in boring blue chip stocks. He’s after explosive investments; companies whose shares trade for cents on the dollar, cryptocurrencies that can deliver life-changing returns. He looks for the ‘edge of the bell curve’ opportunities that are often shunned by those in the financial services industry.

If you’d like to learn about the specific investments Sam is recommending in either small-cap stocks or cryptocurrencies, take a 30-day trial of his small-cap investment advisory Australian Small-Cap Investigator here, or a 30-day trial of his industry leading cryptocurrency service, Sam Volkering’s Secret Crypto Network here.

But that’s not where Sam’s talents end. Sam specialises in finding new, cutting edge tech and translating that research into how the future will look — and where the opportunities lie. It’s his job to trawl the world to find, analyse, research and recommend investments in the world’s most revolutionary companies.

He recommends the best ones he finds in his premium investment service, Revolutionary Tech Investor. Sam goes to the lengths of the globe and works 24/7 to get these opportunities to you before the mainstream catches on. Click here to take a 30-day no-obligation trial of Revolutionary Tech Investor today.

Websites and financial e-letters Sam writes for:

Money Morning Australia